1. Home
  2. NLSP vs AREB Comparison

NLSP vs AREB Comparison

Compare NLSP & AREB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NLSP
  • AREB
  • Stock Information
  • Founded
  • NLSP 2015
  • AREB 2014
  • Country
  • NLSP Switzerland
  • AREB United States
  • Employees
  • NLSP N/A
  • AREB N/A
  • Industry
  • NLSP Biotechnology: Pharmaceutical Preparations
  • AREB Plastic Products
  • Sector
  • NLSP Health Care
  • AREB Industrials
  • Exchange
  • NLSP Nasdaq
  • AREB Nasdaq
  • Market Cap
  • NLSP 12.4M
  • AREB 10.4M
  • IPO Year
  • NLSP 2021
  • AREB N/A
  • Fundamental
  • Price
  • NLSP $2.13
  • AREB $1.36
  • Analyst Decision
  • NLSP
  • AREB
  • Analyst Count
  • NLSP 0
  • AREB 0
  • Target Price
  • NLSP N/A
  • AREB N/A
  • AVG Volume (30 Days)
  • NLSP 268.4K
  • AREB 708.2K
  • Earning Date
  • NLSP 07-22-2025
  • AREB 08-13-2025
  • Dividend Yield
  • NLSP N/A
  • AREB N/A
  • EPS Growth
  • NLSP N/A
  • AREB N/A
  • EPS
  • NLSP N/A
  • AREB N/A
  • Revenue
  • NLSP N/A
  • AREB $9,887,755.00
  • Revenue This Year
  • NLSP N/A
  • AREB N/A
  • Revenue Next Year
  • NLSP N/A
  • AREB N/A
  • P/E Ratio
  • NLSP N/A
  • AREB N/A
  • Revenue Growth
  • NLSP N/A
  • AREB N/A
  • 52 Week Low
  • NLSP $1.30
  • AREB $1.10
  • 52 Week High
  • NLSP $15.59
  • AREB $231.75
  • Technical
  • Relative Strength Index (RSI)
  • NLSP 43.58
  • AREB 40.11
  • Support Level
  • NLSP $2.20
  • AREB $1.13
  • Resistance Level
  • NLSP $2.33
  • AREB $1.43
  • Average True Range (ATR)
  • NLSP 0.25
  • AREB 0.12
  • MACD
  • NLSP -0.07
  • AREB 0.06
  • Stochastic Oscillator
  • NLSP 6.86
  • AREB 49.47

About NLSP NLS Pharmaceutics Ltd.

NLS Pharmaceutics Ltd a clinical-stage biopharmaceutical company focused on the discovery and development of inventive therapies for patients with rare and complex CNS disorders with unmet medical needs. Its compound, mazindol, a triple monoamine reuptake inhibitor and partial orexin receptor 2 agonist, in a proprietary ER formulation, is being developed for the treatment of narcolepsy, IH (follow-on indication), and potentially ADHD (back-up indication). Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.

About AREB American Rebel Holdings Inc.

American Rebel Holdings Inc develops self-defense, safe storage, and patriotic product areas using a wholesale distribution network, utilizing personal appearances, musical venue performances, as well as e-commerce and television. It designs, manufactures, and markets concealed carry products. It offers products ranging in Backpacks, jackets, coats, and Others. The Company views its operations and manages its business as one operating segment engaged in patriotic goods, comprised of safes, soft goods, and beer.

Share on Social Networks: